ANSTO has recognised the indigenous culture and history that surrounds our campus, with the creation of a Dharawal Mural.
Today the independent nuclear regulator, ARPANSA, has released an Inspection Report in relation to ANSTO’s radiopharmaceutical production facilities.
The ANSTO Nuclear Medicine (ANM) project has achieved a new milestone, reaching practical completion for the Molybdenum-99 (Mo-99) production facility, with contractors handing over the facility to the Australian Nuclear Science and Technology Organisation (ANSTO) to complete the final stages of commissioning.
The man behind Australia’s development and advanced manufacturing of nuclear medicine used in hospitals to diagnose cancers and heart disease has been amongst a number of researchers recognised for their achievements at the ANSTO Awards in Nuclear Science and Technology 2017 presentation dinner.
Australian and Sri Lankan medical researchers have forged a new action plan to investigate the causes of a particular form of chronic kidney disease.
An Australian-first cancer treatment facility was the hot topic at the National Particle Therapy Symposium in Adelaide on Monday.
Forty one schools took part in the Top Coder competition which was held for the second year in a row.
Scientist Peter Kabakov spends his days developing advanced and innovative materials foruse in Australian defence technologies, and has been recognised for his contribution.
Australia has been officially welcomed to the Generation IV International Forum (GIF) Framework Agreement, a partnership through which we will contribute to international work on the development of future nuclear energy technologies.
ANSTO has secured $80.2 million in new funding to expand the research capabilities of the Australian Synchrotron.